Coeptis, Inc., a pioneering technology company focused on AI-driven biotech solutions, has successfully closed an additional $5.7 million in its final Series A Preferred Offering, bringing the total financing round to $10 million. This milestone underscores strong investor confidence in Coeptis’ strategic pivot toward technology-driven growth and innovative therapeutic solutions.
PhaseV, a leader in software and machine learning (ML) solutions for clinical trial optimization, has announced its participation in five major industry conferences in the first half of 2025. Senior executives will present groundbreaking advancements in causal inference and adaptive ML tools, demonstrating how AI is reshaping clinical development.
Sup AI, a pioneer in artificial intelligence innovation, announces the integration of DeepSeek into its Multi-LLM platform. This strategic upgrade enhances Sup AI’s ability to cross-reference, verify, and refine AI-generated content by leveraging multiple Large Language Models (LLMs) such as Llama, Claude, ChatGPT, and DeepSeek.
Fabrix.ai, formerly CloudFabrix, has rebranded to reinforce its mission of delivering a Modern Operational Intelligence platform. This transformation marks a pivotal shift towards AI-driven automation, enabling enterprises to build, deploy, and manage AI agents for streamlined IT operations, observability, and automation.
Oracle NetSuite has announced new AI-driven capabilities to help businesses streamline operations, enhance productivity, and improve decision-making. With generative AI and AI agents, organizations can now automate data entry, optimize product configurations, accelerate sales processes, and resolve issues more efficiently—all at no additional cost.
